Tina Ventura
Chief Investor Relations Officer
Replay available
Madrigal Pharmaceuticals, Inc. (MDGL) Q2 2025 Earnings Call
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) Q2 2025 earnings conference call, held 2025-08-05. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Bill Sibbold
Chief Executive Officer
Dave Sorgel
Chief Medical Officer
Marty Deer
Chief Financial Officer
Thomas Smith
Analyst, Learing Partners
Yasmin Rahimi
Analyst, Piper Sandler
Eliana Moo
Analyst, UBS
Andrea Newberg
Analyst, Goldman Sachs
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Madrigal Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:02.134 Good morning and thank you for standing by. 00:00:02.134 -- 00:00:07.500 Welcome to Madrigal Pharmaceutical's second quarter 2025 earnings conference 00:00:07.500 -- 00:00:12.487 call. At this time, all participants are in a listen-only mode. 00:00:12.487 -- 00:00:17.293 After this speaker's presentation, there will be a question and answer session. 00:00:17.293 -- 00:00:21.037 As a reminder, today's conference call is being recorded. 00:00:21.037 -- 00:00:26.043 I would now like to introduce Ms. Tina Ventura, Chief Investor Relations Officer. 00:00:26.043 -- 00:00:28.186 Please go ahead. 00:00:28.186 -- 00:00:32.540 Thank you, Demi. Good morning, everyone, and thank you for joining us to discuss Madrigal's 00:00:32.540 -- 00:00:35.265 second quarter 2025 earnings. 00:00:35.265 -- 00:00:38.891 We issued a press release this morning and posted a slide deck that accompanies this 00:00:38.891 -- 00:00:43.455 webcast on the investor relations section of our website. 00:00:43.458 -- 00:00:48.707 On the call with me today is Bill Sibbold, Chief Executive Officer, Dave Sorgel, Chief 00:00:48.707 -- 00:00:52.473 Medical Officer, and Marty Deer, Chief Financial Officer. 00:00:52.473 -- 00:00:56.697 They'll provide prepared remarks, and then we'll take your questions. 00:00:56.697 -- 00:01:01.243 Please note on slide two, we will be making certain forward-looking statements today. 00:01:01.243 -- 00:01:06.529 We refer you to our SEC filings for a discussion of the risks that may cause actual 00:01:06.529 -- 00:01:10.134 results to differ from the forward-looking statements. 00:01:10.134 -- 00:01:12.978 And with that, I will now turn the call over to Bill. 00:01:12.978 -- 00:01:15.861 Thanks, Tina. Good morning and thanks for joining us. 00:0...